With over 20 years’ of expertise in phage display, IRBM applies its extensive peptide and antibody libraries to discover lead therapeutic candidates.
IRBM’s Elisabetta Bianchi talks about peptide chemistry
This feature article in Chemistry Today, highlights our peptide chemistry team’s extensive expertise in peptide and macrocyclic drug discovery in a range of therapeutic areas and with an impressive track record in the clinic.
The original article was published on (Chimica Oggi – Chemistry Today May/June 2019 – Vol. 37(3))